IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 277 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $329 | +6.1% | 7,582 | +23.7% | 0.00% | -33.3% |
Q4 2023 | $310 | -83.6% | 6,129 | -85.3% | 0.00% | -86.4% |
Q3 2023 | $1,886 | +135.8% | 41,571 | +113.3% | 0.02% | +266.7% |
Q2 2023 | $800 | -99.9% | 19,493 | +53.5% | 0.01% | -14.3% |
Q3 2022 | $562,000 | -79.1% | 12,698 | -82.5% | 0.01% | -75.9% |
Q2 2022 | $2,686,000 | +526.1% | 72,557 | +526.0% | 0.03% | +866.7% |
Q1 2022 | $429,000 | +8.9% | 11,591 | -10.4% | 0.00% | +50.0% |
Q4 2021 | $394,000 | -40.4% | 12,932 | -34.4% | 0.00% | -33.3% |
Q3 2021 | $661,000 | +47.2% | 19,721 | +75.3% | 0.00% | +50.0% |
Q2 2021 | $449,000 | -78.2% | 11,249 | -75.4% | 0.00% | -81.8% |
Q1 2021 | $2,060,000 | +16.0% | 45,808 | +45.8% | 0.01% | +22.2% |
Q4 2020 | $1,776,000 | -30.9% | 31,414 | -42.0% | 0.01% | -43.8% |
Q3 2020 | $2,569,000 | +585.1% | 54,135 | +750.4% | 0.02% | +433.3% |
Q2 2020 | $375,000 | -36.5% | 6,366 | -49.1% | 0.00% | -50.0% |
Q1 2020 | $591,000 | +19.9% | 12,503 | +53.1% | 0.01% | +50.0% |
Q4 2019 | $493,000 | -19.3% | 8,165 | -20.0% | 0.00% | -20.0% |
Q3 2019 | $611,000 | -10.8% | 10,206 | -4.3% | 0.01% | 0.0% |
Q2 2019 | $685,000 | +220.1% | 10,660 | +305.0% | 0.01% | +150.0% |
Q1 2019 | $214,000 | -69.4% | 2,632 | -79.6% | 0.00% | -66.7% |
Q4 2018 | $699,000 | +286.2% | 12,925 | +269.1% | 0.01% | +500.0% |
Q3 2018 | $181,000 | -94.5% | 3,502 | -95.6% | 0.00% | -96.7% |
Q2 2018 | $3,281,000 | +758.9% | 78,744 | +809.1% | 0.03% | +900.0% |
Q1 2018 | $382,000 | +221.0% | 8,662 | +269.2% | 0.00% | +200.0% |
Q3 2017 | $119,000 | -62.9% | 2,346 | -62.9% | 0.00% | -66.7% |
Q2 2017 | $321,000 | +65.5% | 6,315 | +30.9% | 0.00% | +50.0% |
Q1 2017 | $194,000 | -77.5% | 4,826 | -73.2% | 0.00% | -71.4% |
Q4 2016 | $861,000 | +23.5% | 18,004 | +4.6% | 0.01% | +40.0% |
Q1 2016 | $697,000 | -21.9% | 17,214 | +19.3% | 0.01% | -16.7% |
Q4 2015 | $893,000 | – | 14,425 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |